Humacyte reported a gross margin of -203.20% and a net margin of -7,125.37% for the quarter ended Jun 2026. These financial ratios cover 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||
| Gross Margin | 71.57% | 29.24% | 65.47% | -1,844.75% | -311.72% | -203.20% | ||||||||||||||||||
| EBT Margin | -13,096.68% | -4,939.65% | -10,445.18% | -3,507.57% | -7,157.60% | -6,237.58% | -7,125.37% | |||||||||||||||||
| EBIT Margin | -8,524.07% | -4,487.43% | -9,876.08% | -3,239.04% | -6,603.00% | -5,845.45% | -6,649.26% | |||||||||||||||||
| EBITDA Margin | -8,524.07% | -4,487.43% | -9,876.08% | -3,239.04% | -6,603.00% | -5,845.45% | -6,649.26% | |||||||||||||||||
| Operating Margin | -8,524.07% | -4,487.43% | -9,876.08% | -3,239.04% | -6,603.00% | -5,845.45% | -6,649.26% | |||||||||||||||||
| Net Margin | -13,096.68% | -4,939.65% | -10,445.18% | -3,507.57% | -7,157.60% | -6,237.58% | -7,125.37% | |||||||||||||||||
| FCF Margin | -12,697.93% | -5,637.52% | -8,858.47% | -3,181.01% | -5,602.36% | -5,106.87% | -5,467.98% | |||||||||||||||||
| Efficiency | ||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 9.56M | 14.76M | 20.46M | 21.47M | 19.32M | |||||||||||||||||||
| Assets AverageAssets Avg. | 201.94M | 294.95M | 275.50M | 255.42M | 236.29M | 215.26M | 193.64M | 175.54M | 158.75M | 138.80M | 144.84M | 149.87M | 126.52M | 126.32M | 150.21M | 150.67M | 115.15M | 103.94M | 113.46M | 124.32M | ||||
| Invested CapitalInvested Cap. | 93.79M | 149.53M | 133.89M | 172.26M | 147.24M | 145.84M | 111.15M | 97.36M | 74.28M | 52.15M | 84.11M | 31.79M | -1.60M | -51.78M | 102.41M | 418.54M | 15.99M | 38.55M | 47.49M | 67.58M | ||||
| Asset Utilization RatioAsset Util. | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | ||||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -17.06 | -15.48 | -15.22 | -12.45 | -14.32 | -12.69 | -13.25 | -15.63 | -16.83 | -15.14 | -14.65 | -11.73 | -12.40 | -11.20 | -7.73 | -11.68 | -9.34 | -9.97 | -12.74 | -11.63 | ||||
| Debt Ratio | 0.06 | 0.10 | 0.11 | 0.12 | 0.13 | 0.14 | 0.16 | 0.22 | 0.25 | 0.30 | 0.36 | 0.43 | 0.54 | 0.01 | 0.41 | 0.49 | 0.23 | 0.30 | 0.32 | 0.26 | ||||
| Times Interest Earned | -17.06 | -15.48 | -15.22 | -12.45 | -14.32 | -12.69 | -13.25 | -15.63 | -16.83 | -15.14 | -14.65 | -11.73 | -12.40 | -11.20 | -7.73 | -11.68 | -9.34 | -9.97 | -12.74 | -11.63 | ||||
| Return Ratios | ||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -8,524.07% | -9,252.64% | -46,671.78% | -4,487.43% | -9,876.08% | -3,239.04% | -6,603.00% | -5,845.45% | -6,649.26% | |||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -33.11% | -28.60% | -31.43% | -33.75% | -39.12% | -43.25% | -50.19% | -56.98% | -65.92% | -83.09% | -79.61% | -80.89% | -106.53% | -107.58% | -85.28% | -85.85% | -117.68% | -126.40% | -117.08% | -101.63% | ||||
| Return on Assets [ROA]ROA | -36.21% | -32.32% | -35.66% | -38.16% | -38.16% | -40.97% | -45.31% | -54.10% | -60.12% | -72.87% | -73.04% | -73.08% | -92.14% | -94.68% | -78.39% | -78.64% | -98.25% | -112.39% | -107.66% | -96.24% |